Total Versus Subtotal Abdominal Hysterectomy

September 24, 2014 updated by: Lea Laird Andersen, Nykøbing Falster County Hospital

Randomized Clinical Trial of Total Versus Subtotal Abdominal Hysterectomy

319 Women undergoing hysterectomy for benign (not cancer) indications were randomly allocated to 2 types of surgery (Total (TAH) and Subtotal (SAH)) abdominal hysterectomy 15 years ago. They were followed by questionnaire at time of surgery and up to 5 years (not yet published) after the surgery and evaluated regarding following outcomes: Urinary incontinence, pain, bowel problems, per and postoperative complications, sexuality, quality of life, pelvic organ prolapse and vaginal bleeding. Now the investigators are conducting a 15 year follow up with the same out-come measures but also including physical examinations regarding Urinary incontinence, voiding difficulties, pelvic organ prolapse and problems with the cervix. The investigators' hypothesis is that several of the out-come measures will be present in more cases than earlier due to age and menopausal changes. The investigators expect more urinary incontinence in the subtotal group as this was seen at earlier follow ups. The investigators expect to find more women with pelvic organ prolapse with the physical examination than by questionnaire alone, possibly with a higher incidence in the subtotal group.

Study Overview

Detailed Description

The study included women who were offered a hysterectomy for benign uterine disease such as: metrorrhagia, menorrhagia, fibroids, endometriosis,and pelvic pain. Women in need of hysterectomy for malignant disease or because of prolapse of the uterus were not included. They were followed up by a questionnaire covering all outcome measures as described above. Background information was registered in a second questionnaire prior to surgery. All gynaecological departments in Denmark were invited to join the trial. 11 departments contributed randomized patients to the trial.

the results up to 1 year after surgery have been published, links can be found in the citation list. The results from the 5 year follow up have not yet been published.

The questionnaire used in this trial consists of the validated SF-36 (Short Form 36) quality of life questionnaire as well as a thorough questionnaire regarding the outcome measures described elsewhere. The entire questionnaire was validated prior to the beginning of the trial.

A second questionnaire has been added in the 15 year follow up: PFDI-20(Pelvic Floor Distress Inventory 20). The investigators included this, as it is more thorough regarding pelvic organ prolapse and in particular a "bother" measure than the original questionnaire.

The 20 min. pad-weighing test has been tested against the 1 hour gold-standard used by the ICS (International Continence Society) and has been found to give comparable results.

Study Type

Interventional

Enrollment (Actual)

319

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Region Sjaelland
      • Nykoebing Falster, Region Sjaelland, Denmark, 4800
        • Nykoebing Falster County Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

-Women undergoing abdominal hysterectomy for benign uterine disease at a gynaecological department in Denmark (15 years ago)

Exclusion Criteria:

  • malignant disease
  • mental disease
  • diabetes
  • neurological disease
  • not able to read and write Danish
  • pelvic organ prolapse as the reason for hysterectomy
  • prior surgery for urinary incontinence

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Total hysterectomy
removal of the entire uterus including the cervix. open abdominal surgery. No specific procedures were asked of the surgeon. They were free to do the procedure the way they were used to doing it.
total abdominal hysterectomy where the body as well as the cervix of the uterus are removed.
Experimental: Subtotal Hysterectomy
removal of the uterine body only leaving the cervix in situ. The surgeon was free to do the procedure as he was used to. The only direction was that the cervical canal should be electrocoagulated.
Subtotal abdominal hysterectomy where the body of the uterus is removed but the cervix is spared.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Urinary incontinence from baseline (preoperatively)
Time Frame: 2 months, 6months, 1, 5 and 15 years postoperatively
urinary incontinence measured by questionnaire filled out by the participants at each time point as well as a more objective measure: pad weighing test and voiding diary at 15 years
2 months, 6months, 1, 5 and 15 years postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pelvic organ prolapse
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
subjective measure by questionnaire at each time point as well as objective measure by POP-Q measurement at 15 years
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
cervical problems in the SAH group
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
questionnaire regarding bleeding at each time point, pap-smear regarding dysplasia at 15 years discharge summaries from hospital admissions/contacts regarding cervical problems.
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
voiding difficulties and LUTS (Lower Urinary Tract Symptoms)
Time Frame: preoperatively, 2 months, 6 months, 1, 5 and 15 years postoperatively
covered by the questionnaire at each time point regarding urinary tract infections and problems emptying the bladder. In addition the 15 year follow up consists of uroflow, dip-stick for urinary infection as well as post-voiding ultrasound of the bladder to detect urinary retention.
preoperatively, 2 months, 6 months, 1, 5 and 15 years postoperatively

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life
Time Frame: preoperatively, 2 months, 6months, 1 and 15 years postoperatively
SF-36 questionnaire at each time point
preoperatively, 2 months, 6months, 1 and 15 years postoperatively
sexuality
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
questionnaire at each time point
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
pelvic pain
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
questionnaire at each time point
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
bowel problems
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
questionnaire at each time point
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
per- and postoperative complications
Time Frame: preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively
questionnaire at each time points and case records regarding related surgery (hernia, bowel obstruction, removal of the cervix, surgery for urinary incontinence and pelvic organ prolapse)looked up in the clinical registry
preoperatively, 2 months, 6months, 1, 5 and 15 years postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lea L Andersen, MD, Nykoebing Falster County Hospital
  • Study Director: Helga ME Gimbel, Dr.med.sci., University of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

February 1, 2014

Study Registration Dates

First Submitted

May 14, 2013

First Submitted That Met QC Criteria

June 14, 2013

First Posted (Estimate)

June 19, 2013

Study Record Updates

Last Update Posted (Estimate)

September 25, 2014

Last Update Submitted That Met QC Criteria

September 24, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • sj-268

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Benign Uterine Disease

Clinical Trials on Total Hysterectomy

Subscribe